NFKB1 and cancer: Since interference exists between these two pathways, their concomitant modulation, i.e., induction of Nrf2 and inhibition of NF-κB in normal cells and inhibition of both in cancer cells, may be considered the best strategy of cancer chemoprevention and therapy, respectively.